دورية أكاديمية
Prospects for the use of olfactory mucosa cells in bioprinting for the treatment of spinal cord injuries.
| العنوان: | Prospects for the use of olfactory mucosa cells in bioprinting for the treatment of spinal cord injuries. |
|---|---|
| المؤلفون: | Stepanova OV; Department of Basic and Applied Neurobiology, V.P. Serbsky National Medical Research Center for Psychiatry and Narcology, Moscow 119034, Russia.; Department of Neurohumoral and Immunological Research, National Medical Research Center of Cardiology, Moscow 121552, Russia. sms-34@yandex.ru., Fursa GA; Department of Basic and Applied Neurobiology, V.P. Serbsky National Medical Research Center for Psychiatry and Narcology, Moscow 119034, Russia., Andretsova SS; Department of Basic and Applied Neurobiology, V.P. Serbsky National Medical Research Center for Psychiatry and Narcology, Moscow 119034, Russia.; Department of Biology, Moscow State University, Moscow 119991, Russia., Shishkina VS; Department of Basic and Applied Neurobiology, V.P. Serbsky National Medical Research Center for Psychiatry and Narcology, Moscow 119034, Russia., Voronova AD; Department of Basic and Applied Neurobiology, V.P. Serbsky National Medical Research Center for Psychiatry and Narcology, Moscow 119034, Russia., Chadin AV; Department of Basic and Applied Neurobiology, V.P. Serbsky National Medical Research Center for Psychiatry and Narcology, Moscow 119034, Russia., Karsuntseva EK; Department of Basic and Applied Neurobiology, V.P. Serbsky National Medical Research Center for Psychiatry and Narcology, Moscow 119034, Russia., Reshetov IV; Department of Plastic Surgery, I.M. Sechenov First Moscow State Medical University, Moscow 119435, Russia., Chekhonin VP; Department of Basic and Applied Neurobiology, V.P. Serbsky National Medical Research Center for Psychiatry and Narcology, Moscow 119034, Russia.; Department of Medical Nanobiotechnologу, N.I. Pirogov Russian National Research Medical University, Moscow 117997, Russia. |
| المصدر: | World journal of clinical cases [World J Clin Cases] 2023 Jan 16; Vol. 11 (2), pp. 322-331. |
| نوع المنشور: | Journal Article; Review |
| اللغة: | English |
| بيانات الدورية: | Publisher: Baishideng Publishing Group Country of Publication: United States NLM ID: 101618806 Publication Model: Print Cited Medium: Print ISSN: 2307-8960 (Print) Linking ISSN: 23078960 NLM ISO Abbreviation: World J Clin Cases Subsets: PubMed not MEDLINE |
| أسماء مطبوعة: | Publication: 2014-: Pleasanton, CA : Baishideng Publishing Group Original Publication: Hong Kong, China : Baishideng Publishing Group Co., Limited, [2013]- |
| مستخلص: | The review focuses on the most important areas of cell therapy for spinal cord injuries. Olfactory mucosa cells are promising for transplantation. Obtaining these cells is safe for patients. The use of olfactory mucosa cells is effective in restoring motor function due to the remyelination and regeneration of axons after spinal cord injuries. These cells express neurotrophic factors that play an important role in the functional recovery of nerve tissue after spinal cord injuries. In addition, it is possible to increase the content of neurotrophic factors, at the site of injury, exogenously by the direct injection of neurotrophic factors or their delivery using gene therapy. The advantages of olfactory mucosa cells, in combination with neurotrophic factors, open up wide possibilities for their application in three-dimensional and four-dimensional bioprinting technology treating spinal cord injuries. Competing Interests: Conflict-of-interest statement: There is no conflict of interest associated with any of the senior authors or other co-authors who contributed their efforts to this manuscript. (©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.) |
| References: | Int J Mol Sci. 2012 Oct 10;13(10):12911-24. (PMID: 23202929) Biofabrication. 2013 Dec;5(4):045007. (PMID: 24192236) Nat Med. 2019 Feb;25(2):263-269. (PMID: 30643285) Oncotarget. 2017 Oct 24;8(56):96276-96289. (PMID: 29221205) Neurosurgery. 2000 Nov;47(5):1057-69. (PMID: 11063098) Int J Mol Sci. 2021 Jun 28;22(13):. (PMID: 34203489) Methods Mol Biol. 2018;1727:1-17. (PMID: 29222769) Glia. 2000 May;30(3):209-18. (PMID: 10756071) Brain. 2005 Dec;128(Pt 12):2951-60. (PMID: 16219671) Neurobiol Dis. 2007 May;26(2):363-74. (PMID: 17346980) Int Arch Med. 2010 Nov 11;3:30. (PMID: 21070647) Bull Exp Biol Med. 2021 May;171(1):122-126. (PMID: 34046791) Int J Nanomedicine. 2019 Jun 11;14:4333-4351. (PMID: 31354264) PLoS One. 2014 Sep 12;9(9):e107517. (PMID: 25215612) Mol Biol Rep. 2022 Jun;49(6):4435-4441. (PMID: 35348963) Neural Regen Res. 2020 Sep;15(9):1686-1700. (PMID: 32209773) Eur Spine J. 2007 Dec;16(12):2206-14. (PMID: 17885772) J Neurosci Res. 2021 Jun;99(6):1579-1597. (PMID: 33605466) Biomaterials. 2016 Dec;109:1-11. (PMID: 27639527) Acta Neurochir (Wien). 2016 Feb;158(2):367-78. (PMID: 26592254) Glia. 2016 Dec;64(12):2154-2165. (PMID: 27534509) Mater Sci Eng C Mater Biol Appl. 2020 May;110:110741. (PMID: 32204049) Front Bioeng Biotechnol. 2019 Jul 09;7:164. (PMID: 31338366) Br J Neurosurg. 2011 Aug;25(4):516-22. (PMID: 21749185) Neuroscience. 2016 May 13;322:377-97. (PMID: 26917272) Biomaterials. 2015 Dec;71:48-57. (PMID: 26318816) J Neurotrauma. 2020 Mar 1;37(5):817-829. (PMID: 32056492) Brain Res. 2010 Nov 4;1359:256-71. (PMID: 20816761) Proc Natl Acad Sci U S A. 2002 Mar 5;99(5):3246-51. (PMID: 11867727) Exp Neurol. 1996 Aug;140(2):218-29. (PMID: 8690064) J Neurosci Res. 2004 Mar 1;75(5):632-41. (PMID: 14991839) Cell Transplant. 2018 Jun;27(6):907-915. (PMID: 29871514) Biomaterials. 2021 Apr;271:120762. (PMID: 33773400) Glia. 2007 Feb;55(3):303-11. (PMID: 17096411) J Tissue Eng Regen Med. 2019 Jun;13(6):925-945. (PMID: 30812062) Bull Exp Biol Med. 2020 Feb;168(4):538-541. (PMID: 32157509) Front Pharmacol. 2022 Jan 10;12:777628. (PMID: 35082666) J Neurotrauma. 2007 Dec;24(12):1863-77. (PMID: 18159998) Genes Dis. 2017 Jun;4(2):43-63. (PMID: 28944281) Cell Transplant. 2010;19(2):167-77. (PMID: 20350361) Brain. 2005 Apr;128(Pt 4):839-53. (PMID: 15716305) Neural Regen Res. 2021 Mar;16(3):405-413. (PMID: 32985458) Exp Cell Res. 2002 Sep 10;279(1):34-9. (PMID: 12213211) Neurochem Int. 2007 Feb;50(3):491-8. (PMID: 17157963) Neural Regen Res. 2014 Aug 15;9(16):1520-4. (PMID: 25317169) Cell Transplant. 2018 Jun;27(6):867-878. (PMID: 29852748) Cell Transplant. 2013;22(9):1591-612. (PMID: 24007776) Jpn J Vet Res. 2014 Nov;62(4):151-62. (PMID: 25597185) Adv Biosyst. 2018 Sep;2(9):. (PMID: 30906853) Stem Cells Transl Med. 2021 Jul;10(7):1008-1020. (PMID: 33586908) Stem Cells Dev. 2019 Sep 15;28(18):1253-1263. (PMID: 31310179) Front Cell Neurosci. 2021 Dec 02;15:773375. (PMID: 34924958) Mol Neurodegener. 2012 Feb 08;7:6. (PMID: 22315999) J Mater Chem B. 2020 Dec 21;8(47):10712-10738. (PMID: 33155614) J Comp Neurol. 2004 May 17;473(1):1-15. (PMID: 15067714) Biofabrication. 2021 Sep 27;13(4):. (PMID: 34530408) Transl Neurosci. 2021 Nov 30;12(1):494-511. (PMID: 34900347) Adv Healthc Mater. 2018 Jul;7(14):e1800315. (PMID: 29920990) Cytotherapy. 2016 Oct 28;:. (PMID: 28029610) Glia. 2010 Jan 15;58(2):125-34. (PMID: 19606497) Adv Sci (Weinh). 2020 Feb 18;7(6):1902403. (PMID: 32195081) Cell Tissue Res. 2012 Jul;349(1):27-37. (PMID: 22526621) Neurosurgery. 2020 Sep 15;87(4):E456-E472. (PMID: 32497197) Biomaterials. 2021 May;272:120771. (PMID: 33798962) Glia. 2013 Mar;61(3):368-82. (PMID: 23281012) Cell Transplant. 2014;23(4-5):573-611. (PMID: 24816452) Brain Res. 2018 Nov 15;1699:19-33. (PMID: 29883625) Stem Cells Int. 2019 Sep 2;2019:9807978. (PMID: 31565061) Am J Physiol Heart Circ Physiol. 2021 May 1;320(5):H1959-H1974. (PMID: 33769916) Neural Regen Res. 2020 Nov;15(11):2016-2026. (PMID: 32394949) Bull Exp Biol Med. 2018 May;165(1):132-135. (PMID: 29796806) J Neurotrauma. 2000 Dec;17(12):1219-31. (PMID: 11186234) Asian Spine J. 2018 Dec;12(6):998-1009. (PMID: 30322257) Stem Cells Dev. 2022 Jan;31(1-2):9-17. (PMID: 34847755) Cell Transplant. 2016;25(8):1425-38. (PMID: 26850705) Spinal Cord. 2022 Jan;60(1):63-70. (PMID: 34504283) Exp Neurobiol. 2019 Dec 31;28(6):679-696. (PMID: 31902156) Exp Neurol. 2005 Jul;194(1):12-30. (PMID: 15899240) Biomed Mater. 2008 Sep;3(3):034101. (PMID: 18689930) J Neurosci. 2003 Aug 6;23(18):7045-58. (PMID: 12904465) Bull Exp Biol Med. 2022 May;173(1):114-118. (PMID: 35622252) Glia. 2007 Mar;55(4):352-9. (PMID: 17136772) |
| فهرسة مساهمة: | Keywords: Cell therapy; Four-dimensional bioprinting; Injury of spinal cord; Neurotrophic factors; Olfactory mucosa cells; Three-dimensional bioprinting |
| تواريخ الأحداث: | Date Created: 20230123 Latest Revision: 20230202 |
| رمز التحديث: | 20231215 |
| مُعرف محوري في PubMed: | PMC9850961 |
| DOI: | 10.12998/wjcc.v11.i2.322 |
| PMID: | 36686356 |
| قاعدة البيانات: | MEDLINE |
| تدمد: | 2307-8960 |
|---|---|
| DOI: | 10.12998/wjcc.v11.i2.322 |